ROS-DET: Robust detector of switching mechanisms in gene expression

Nucleic Acids Research

Volumn 39, Issue 11, 2011, Pages

  Kayano, Mitsunori ^a,b   Takigawa, Ichigaku ^a,b   Shiga, Motoki ^a,b   Tsuda, Koji ^b,c   Mamitsuka, Hiroshi ^a,b  

^a KYOTO UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE SWITCHING; INTERMETHOD COMPARISON; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; VALIDATION PROCESS;

DATA INTERPRETATION, STATISTICAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; ROC CURVE;

EID: 79959390443     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkr130     Document Type: Article

References (47)

1. Pan, W. (2002) A comparative review of statistical methods for discovering differentially expressed genes in replicated microarray experiments. Bioinformatics, 18, 546.
2. Stuart, J.M., Segal, E., Koller, D. and Kim, S.K. (2003) A genecoexpression network for global discovery of conserved genetic modules. Science, 302, 249.
3. Ho, Y., Cope, L., Dettling, M. and Parmigiani, G. (2007) Statistical methods for identifying differentially expressed gene combinations. Methods Mol. Biol., 408, 171.
4. Cho, S.B., Kim, J. and Kim, J.H. (2009) Identifying set-wise differential co-expression in gene expression microarray data. BMC Bioinformatics, 10, 109.
5. Li, K.C. (2002) Genome-wide coexpression dynamics: theory and application. Proc. Natl Acad. Sci. USA, 99, 16875.
6. Dettling, M., Gabrielson, E. and Parmigiani, G. (2005) Searching for differentially expressed gene combinations. Genome Biol., 6, R88.
7. Watson, M. (2006) CoXpress: differential co-expression in gene expression data. BMC Bioinformatics, 7, 509.
8. Kayano, M., Takigawa, I., Shiga, M., Tsuda, K. and Mamitsuka, H. (2009) Efficiently finding genome-wide three-way gene interactions from transcript- and genotype-data. Bioinformatics, 25, 2735.
9. Ayer, D.E. and Eisenman, R.N. (1993) A switch from Myc: Max to Mad: Max heterocomplexes accompanies monocyte/macrophage differentiation. Genes Dev., 7, 2110.
10. Lazar, M.A. (2003) Thyroid hormone action: a binding contract. J. Clin. Invest., 112, 497-499. (Pubitemid 38056333)
11. Cordell, H.J. (2002) Epistasis: what it means, what it doesn't mean, and statistical methods to detect it in humans. Hum. Mol. Genet., 11, 2463.
12. Wilcox, R.R. (2005) Introduction to Robust Estimation and Hypothesis Testing. Academic Press, San Diego.
13. Shedden, K. and Taylor, J. (2004) Differential correlation detects complex associations between gene expression and clinical outcomes in lung adenocarcinomas. Methods Microarray Data Anal., 4, 121-131.
14. Hardin, J., Mitani, A., Hicks, L. and VanKoten, B. (2007) A robust measure of correlation between two genes on a microarray. BMC Bioinformatics, 8, 220.
15. Lax, D.A. (1985) Robust estimators of scale: finite-sample performance in long-tailed symmetric distributions. J. Am. Stat. Assoc., 80, 736-741.
16. Hoaglin, D.C., Mosteller, F. and Tukey, J.W. (1983) Understanding Robust and Exploratory Data Analysis. Wiley, New York.
17. Paul, S.R. (1989) Test for the equality of several correlation coefficients. Can. J. Stat., 17, 217-227.
18. Pearson, K. (1933) On a method of determining whether a sample of size n supposed to have been drawn from a parent population having a known probability integral has probably been drawn at random. Biometrika, 25, 379.
19. Wilcox, R.R. and Muska, J. (2002) Comparing correlation coefficients. Commun. Stat. Simul. Comput., 31, 49-59.
20. Bartlett, M.S. (1937) Properties of sufficiency and statistical tests. Proc. R. Soc. Lond. A., 160, 268-282.
21. Barrett, T., Troup, D.B., Wilhite, S.E., Ledoux, P., Rudnev, D., Evangelista, C., Kim, I.F., Soboleva, A., Tomashevsky, M. and Edgar, R. (2007) NCBI GEO: mining tens of millions of expression profiles-database and tools update. Nucleic Acids Res., 35, D760.
22. Bavner, A., Matthews, J., Sanyal, S., Gustafsson, J.A. and Treuter, E. (2005) EID3 is a novel EID family member and an inhibitor of CBP-dependent co-activation. Nucleic Acids Res., 33, 3561.
23. Toledo, F. and Wahl, G.M. (2006) Regulating the p53 pathway: in vitro hypotheses, in vivo veritas. Nat. Rev. Cancer, 6, 909-923. (Pubitemid 44862676)
24. Li, M., Brooks, C.L., Kon, N. and Gu, W. (2004) A dynamic role of HAUSP in the p53-Mdm2 pathway. Mol. Cell, 13, 879-886. (Pubitemid 38438482)
25. Li, M., Chen, D., Shiloh, A., Luo, J., Nikolaev, A.Y., Qin, J. and Gu, W. (2002) Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature, 416, 648-653. (Pubitemid 34406767)
26. Peterson, D., Lee, J., Lei, X.C., Forrest, W.F., Davis, D.P., Jackson, P.K. and Belmont, L.D. (2010) A chemosensitization screen identifies TP53RK, a kinase that restrains apoptosis after mitotic stress. Cancer Res., 70, 6325-6335.
27. Dube, D.H. and Bertozzi, C.R. (2005) Glycans in cancer and inflammation potential for therapeutics and diagnostics. Nat. Rev. Drug Discov., 4, 477-488. (Pubitemid 40861990)
28. Fuster, M.M. and Esko, J.D. (2005) The sweet and sour of cancer: glycans as novel therapeutic targets. Nat. Rev. Cancer, 5, 526-542. (Pubitemid 40942829)
29. Sasisekharan, R., Shriver, Z., Venkataraman, G. and Narayanasami, U. (2002) Roles of heparan-sulphate glycosaminoglycans in cancer. Nat. Rev. Cancer, 2, 521-528. (Pubitemid 37328933)
30. Blackhall, F.H., Merry, C.L.R., Davies, E.J. and Jayson, G.C. (2001) Heparan sulfate proteoglycans and cancer. Br. J. Cancer, 85, 1094.
31. Atsumi, S., Nosaka, C., Ochi, Y., Iinuma, H. and Umezawa, K. (1993) Inhibition of experimental metastasis by an {alpha} -glucosidase inhibitor, 1, 6-epi-cyclophellitol. Cancer Res., 53, 4896.
32. Pili, R., Chang, J., Partis, R.A., Mueller, R.A., Chrest, F.J. and Passaniti, A. (1995) The {alpha}-glucosidase I inhibitor castanospermine alters endothelial cell glycosylation, prevents angiogenesis, and inhibits tumor growth. Cancer Res., 55, 2920.
33. Baldwin, T.A. and Ostergaard, H.L. (2001) Developmentally regulated changes in glucosidase II association with, and carbohydrate content of, the protein tyrosine phosphatase CD45. J. Immunol., 167, 3829.
34. Salmond, R.J., Filby, A., Qureshi, I., Caserta, S. and Zamoyska, R. (2009) T-cell receptor proximal signaling via the Src-family kinases, Lck and Fyn, influences T-cell activation, differentiation, and tolerance. Immunol. Rev., 228, 9-22, 2009.
35. Taher, T.E.I., Smit, L., Griffioen, A.W., Schilder-Tol, E.J.M., Borst, J. and Pals, S.T. (1996) Signaling through cd44 is mediated by tyrosine kinases. association with p56lck in t lymphocytes. J. Biol. Chem., 271, 2863-2867.
36. Hernaiz, M., Liu, J., Rosenberg, R.D. and Linhardt, R.J. (2000) Enzymatic modification of heparan sulfate on a biochip promotes its interaction with antithrombin III. Biochem. Biophys. Res. Commun., 276, 292-297.
37. Liu, J. and Pedersen, L.C. (2007) Anticoagulant heparan sulfate: structural specificity and biosynthesis. Appl. Microbiol. Biotechnol., 74, 263-272. (Pubitemid 46204499)
38. Pellegrini, L., Burke, D.F., Von Delft, F., Mulloy, B. and Blundell, T.L. (2000) Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin. Nature, 407, 1029-1034.
39. Mizukoshi, E., Suzuki, M., Loupatov, A., Uruno, T., Hayashi, H., Misono, T., Kaul, S.C., Wadhwa, R. and Imamura, T. (1999) Fibroblast growth factor-1 interacts with the glucose-regulated protein GRP75/mortalin. Biochem. J., 343(Pt 2), 461.
40. Wadhwa, R., Yaguchi, T., Hasan, M.K., Mitsui, Y., Reddel, R.R. and Kaul, S.C. (2002) Hsp70 family member, mot-2/mthsp70/GRP75, binds to the cytoplasmic sequestration domain of the p53 protein. Exp. Cell Res., 274, 246-253.
41. Godar, S., Ince, T.A., Bell, G.W., Feldser, D., Donaher, J.L., Bergh, J., Liu, A., Miu, K., Watnick, R.S., Reinhardt, F. et al. (2008) Growth-inhibitory and tumor-suppressive functions of p53 depend on its repression of CD44 expression. Cell, 134, 62-73, 2008. (Pubitemid 351905743)
42. Xu, X.N. and Screaton, G. (2001) HIV-1 Nef: negative effector of Fas? Nat. Immunol., 2, 384-386.
43. Seto, E., Usheva, A., Zambetti, G.P., Momand, J., Horikoshi, N., Weinmann, R., Levine, A.J. and Shenk, T. (1992) Wild-type p53 binds to the TATA-binding protein and represses transcription. Proc. Natl Acad. Sci. USA, 89, 12028.
44. Giangrande, P.H., Hallstrom, T.C., Tunyaplin, C., Calame, K. and Nevins, J.R. (2003) Identification of E-box factor TFE3 as a functional partner for the E2F3 transcription factor. Mol. Cell. Biol., 23, 3707.
45. Rossow, K.L. and Janknecht, R. (2003) Synergism between p68 RNA helicase and the transcriptional coactivators CBP and p300. Oncogene, 22, 151-156. (Pubitemid 36152893)
46. An, W., Kim, J. and Roeder, R.G. (2004) Ordered cooperative functions of PRMT1, p300, and CARM1 in transcriptional activation by p53. Cell, 117, 735-748. (Pubitemid 38748890)
47. Martin, T.A., Harrison, G., Mansel, R.E. and Jiang, W.G. (2003) The role of the CD44/ezrin complex in cancer metastasis. Crit. Rev. Oncol. Hematol., 46, 165-186, 2003. (Pubitemid 36452345)